FIELD: biotechnology.
SUBSTANCE: invention refers to treating cancer in a subject. Method comprises administering to a subject an effective amount of activated T-cells or activated PBMC, obtained by co-culturing a population of T-cells with a population of dendritic cells, loaded with a plurality of tumor antigenic peptides or bringing the PBMC population into contact with a plurality of tumor antigenic peptides.
EFFECT: invention widens the range of available technical means.
69 cl, 5 tbl, 8 ex, 36 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITIONS AND METHODS FOR PRODUCING T-CELLS | 2018 |
|
RU2793344C2 |
| METHODS OF TREATMENT OF DISEASES ASSOCIATED WITH HPV | 2019 |
|
RU2799784C2 |
| METHOD FOR TREATING CANCER | 2016 |
|
RU2770447C2 |
| METHODS OF EXPANSION OF ANTIGEN-SPECIFIC CAR-T-CELLS, COMPOSITIONS AND THEIR USE | 2019 |
|
RU2800920C2 |
| DELIVERY OF BIOMOLECULES INTO CELLS OF IMMUNE SYSTEM | 2015 |
|
RU2739794C2 |
| COMBINED DRUGS FOR TREATMENT OF CANCER OR INFECTION | 2016 |
|
RU2777945C2 |
| METHODS AND COMPOSITIONS FOR TREATING TUMORS | 2017 |
|
RU2741786C2 |
| COMPOSITIONS AND METHODS OF TREATING INFECTIONS AND TUMOURS | 2007 |
|
RU2540490C2 |
| INTRACELLULAR DELIVERY OF BIOMOLECULES FOR IMMUNE RESPONSE MODULATION | 2019 |
|
RU2819143C2 |
| METHODS FOR MODULATING CART-CELLS | 2017 |
|
RU2774232C2 |
